Biotropics is an enterprise that engages in the R&D, discovery, identification, commercial extraction, manufacturing and marketing of high-value herbal based products. Its portfolio of successful products that it currently exports to the USA, Canada, Japan and Hong Kong include herbal supplements based on Eurycoma longifolia (Tongkat Ali) and Labisia pumila (Kacip Fatimah). The manufacturing arm of Biotropics, Phytes Biotek Sdn Bhd obtained the US Food and Drug Administration (FDA) certification for its extraction facility in 2012, assuring customers worldwide that the facility complies with international standards of health and safety.

In collaboration with Universiti Sains Malaysia from 2012 to 2015, Biotropics spearheaded a project to develop high-value nutraceutical products, which are all-natural non-modified health supplements. This project included providing funding for pre-clinical and clinical trials on the products, along with giving researchers the opportunity to present at symposiums. Such initiatives are necessary if the health benefits of products manufactured by Biotropics are to be scientifically substantiated in order to gain credibility among the scientific community.

Credibility from a scientific perspective in turn allows Biotropics to fulfill regulatory requirements and become competitive in the global market. The company has also been recognised by the American Botanical Council as a leading company in terms of research and promotion of local ingredients in the global market. Biotropics has also been an active participant in industry conferences, with its Physta Tongkat Ali extract selected as the “Industry Success Story” in the “Healthy Aging” category at the Vitafoods Europe Conference 2016, the leading nutraceutical event globally.

The Vitafoods Europe Conference is a platform bridging the gap between science and industry, facilitating the sharing of knowledge and formation of partnerships. Biotropics active collaboration with institutions of education and heavy investment into R&D are the main drivers for its strong reception in the US market, raising the productivity of its workers as the herbal products it manufactures are able to command a premium in export markets abroad.

Source: Biotropics Malaysia Berhad.